In conclusion, we showed that the both PI3K inhibitors, BKM120 and GDC0980, induced antiproliferative effects and effectively inhibited the pathway though they did not enhance the RT response in HNSCC cells. Here, PIK3CA is linked to head and neck squamous cell carcinoma.